| abstract |
The present invention comprises administering a therapeutically effective amount of a compound of formula (I) to a mammal, including a human, in need of treatment of a condition mediated by cannabinoid (CB) 1 receptor activity Compounds, pharmaceutical compositions and methods for the treatment of symptoms mediated by: Formula I Where R 1 , R 2 and R 3 are as defined herein. |